An introduction to personalised medicine & health in Leeds Diagnostic Evidence Co-operative Leeds An introduction to personalised medicine & health in Leeds Michael Messenger, Deputy Director NIHR DEC Leeds A partnership between the NHS, patients, academia, industry and charities

A Vision for Leeds

The Personalised Health & Care Journey Hospital admission Recovery Late side-effects Chronic disease relapse Death Hospital discharge Acute disease diagnosed Disease response Treatment initiation Prediction & Prevention Early Diagnosis Treatment benefit / response Monitoring Symptomatic Disease Asymptomatic Disease Free Disease Screening Molecular Phenotyping Prognosis Shift towards individualised prevention

Marry to assets on previous slide – in particular unis Translational Gap 1 Translational Gap 2 We want to understand the H and W Strategy - first slide - in terms of problems and challenges Marry to assets on previous slide – in particular unis So we can innovate to improve health etc Need a collaborative framework to do that

Centre for Personalised Medicine and Health Establish the evidence base to accelerate PM technologies into routine clinical practice